Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-19 4:30 pm Purchase |
2022-08-12 | 13G | Silence Therapeutics plc SLN |
TCG Crossover Management LLC | 6,314,625 5.900% |
6,314,625 (New Position) |
Filing History |
| 2022-07-20 4:00 pm Purchase |
2022-07-19 | 13D | Silence Therapeutics plc SLN |
Griffiths Richard Ian | 25,469,271 28.400% |
1,187,562 (+4.89%) |
Filing History |
| 2022-06-15 4:31 pm Purchase |
2022-06-08 | 13D | Silence Therapeutics plc SLN |
Griffiths Richard Ian | 24,281,709 27.000% |
3,585,357 (+17.32%) |
Filing History |
| 2022-02-14 4:57 pm Sale |
2021-12-31 | 13G | Silence Therapeutics plc SLN |
Quested Robert | 7,004,127 7.810% |
-616,152 (-8.09%) |
Filing History |
| 2022-02-14 4:54 pm Sale |
2021-12-31 | 13G | Silence Therapeutics plc SLN |
Griffiths Richard Ian | 20,696,352 23.050% |
-169,496 (-0.81%) |
Filing History |
| 2022-02-10 4:44 pm Sale |
2021-12-31 | 13G | Silence Therapeutics plc SLN |
Lombard Odier Asset Management (USA) Corp | 10,417,563 11.600% |
-503,008 (-4.61%) |
Filing History |
| 2022-02-07 4:01 pm Purchase |
2021-12-31 | 13G | Silence Therapeutics plc SLN |
Mallinckrodt plc MNKTQ |
5,062,167 5.640% |
5,062,167 (New Position) |
Filing History |
| 2022-01-27 2:51 pm Purchase |
2021-12-31 | 13G | Silence Therapeutics plc SLN |
GOLDMAN SACHS GROUP INC GS |
4,828,417 5.400% |
4,828,417 (New Position) |
Filing History |
| 2021-02-17 3:53 pm Purchase |
2020-12-31 | 13G | Silence Therapeutics plc SLN |
Keith Robert Napier | 12,287,964 13.700% |
12,287,964 (New Position) |
Filing History |
| 2021-02-17 3:47 pm Purchase |
2020-12-31 | 13G | Silence Therapeutics plc SLN |
Griffiths Richard Ian | 20,865,848 23.300% |
20,865,848 (New Position) |
Filing History |
| 2021-02-17 3:46 pm Purchase |
2020-12-31 | 13G | Silence Therapeutics plc SLN |
Quested Robert | 7,620,279 8.500% |
7,620,279 (New Position) |
Filing History |
| 2021-02-12 6:02 pm Purchase |
2020-12-31 | 13G | Silence Therapeutics plc SLN |
Lombard Odier Asset Management (USA) Corp | 10,920,571 12.200% |
10,920,571 (New Position) |
Filing History |